SKI Market

A+| A| A-|

Indian Indices

Sensex

77,664.00 -852.49
( -1.09%)

Global Indices

Nasdaq

49,509.71 339.32
(0.69%)

Dow Jones

7,158.76 73.75
(1.04%)

Hang Seng

59,249.10 -336.76
(-0.57%)

Nikkei 225

10,468.22 -8.24
(-0.08%)

Forex

USD-INR

93.44 0.45
(0.48%)

EUR-INR

109.88 0.43
(0.39%)

GBP-INR

126.24 0.55
(0.44%)

JPY-INR

0.59 0.00
(0.27%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

36.79

34689.63

EPS(TTM)

Face Value()

Div & Yield %

75.48

1.01

Back

Manipal Finance Corporation reports standalone net loss of Rs 0.01 crore in the September 2025 quarter

Nov 15,2025

Net Loss of Manipal Finance Corporation reported to Rs 0.01 crore in the quarter ended September 2025 as against net loss of Rs 0.02 crore during the previous quarter ended September 2024. Sales declined 37.50% to Rs 0.05 crore in the quarter ended September 2025 as against Rs 0.08 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.05	0.08	-38
OPM %	40.00	37.50	-
PBDT	-0.01	-0.02	50
PBT	-0.01	-0.02	50
NP	-0.01	-0.02	50

77,664.00 -852.49 ( -1.09%)

49,509.71 339.32 (0.69%)

7,158.76 73.75 (1.04%)

59,249.10 -336.76 (-0.57%)

10,468.22 -8.24 (-0.08%)

93.44 0.45 (0.48%)

109.88 0.43 (0.39%)

126.24 0.55 (0.44%)

0.59 0.00 (0.27%)